Brain Tumor, Adult - 25 Studies Found
Active, not recruiting |
: Vaccine Therapy With Bevacizumab Versus Bevacizumab Alone in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery :
: |
Recruiting |
: Carboplatin in Treating Patients With Recurrent High-Grade Gliomas :
|
Completed |
: Magnetic Resonance Spectroscopy Imaging in Predicting Response to Vorinostat and Temozolomide in Patients With Recurrent or Progressive Glioblastoma :
|
Completed |
: Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma :
|
Recruiting |
: Sorafenib Tosylate, Valproic Acid, and Sildenafil Citrate in Treating Patients With Recurrent High-Grade Glioma :
|
Terminated |
: Risk Factors for Adult-Onset Brain Tumors :
|
Completed |
: Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors :
|
Recruiting |
: NovoTTF-100A With Bevacizumab (Avastin) in Patients With Recurrent Glioblastoma :
|
Completed |
: Tandutinib in Treating Patients With Recurrent or Progressive Glioblastoma :
: |
Active, not recruiting |
: Dovitinib in Treating Patients With Recurrent or Progressive Glioblastoma :
|